Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: A prospective, randomized, double-blind multicenter study

被引:5
|
作者
Mahjoub, Lobna [1 ]
Youssef, Rym [1 ]
Yaakoubi, Hajer [1 ]
Ben Salah, Houda [1 ]
Jaballah, Rahma [1 ]
Mejri, Moez [1 ]
Sekma, Adel [2 ]
Trabelsi, Imen [2 ]
Nouira, Semir [2 ]
Khrouf, Mariem [3 ]
Ben Soltane, Houda [3 ]
Mezgar, Zied [3 ]
Boukadida, Lotfi [1 ]
Zorgati, Asma [1 ]
Boukef, Riadh [1 ]
机构
[1] Sahloul Univ Hosp, Emergency Dept, Sousse 4011, Tunisia
[2] Monastir Univ, Res Lab LR12SP18, Monastir 5019, Tunisia
[3] Farhat Hached Univ Hosp, Emergency Dept, Sousse 4031, Tunisia
关键词
Melatonin; Zinc; Vitamin C; Vitamin D; Covid-19; Emergency department; INFECTION; ZINC;
D O I
10.1016/j.explore.2023.06.009
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Melatonin, zinc, and multivitamins are among most recommended supplements in the fight against coronavirus disease 2019 (COVID-19). We aimed to examine the efficacy and safety of this association in the treatment of COVID-19 and COVID-like illnesses. Methods: We conducted a multicenter prospective, randomized, double-blind, controlled trial. Patients with no medical history consulting the emergency department for covid and covid-like illness and who were not hospitalized were included. Patients were assigned in a 1:1 ratio to the treatment or the placebo group. The primary outcome was studying the effectiveness of zinc multivitamin supplement and melatonin in the treatment of COVID and -like illnesses symptoms' according to the time from randomization to clinical improvement. The prespecified secondary outcomes were date of disappearance of symptoms present on admission, appearance of an adverse effect due to the administration of the treatment, number of patients developing complications, requiring hospitalization, requiring respiratory support. Results: One hundred sixty four patients were eligible for the study and were randomized to either the treatment group or the placebo group. Overall, 128 of the 164 patients had a PCR for SARS-CoV-2, yielding a positive PCR result in 49.1% of them. Regarding the disappearance of all initial presenting symptoms: on the 5(th) day of the follow-up, there was a significant difference between the two groups with a p value 0.04;On the 10th day, there was a significant difference too with p value of 0.038. There were no significant differences between the two groups in recovery during the 15th day of follow-up p>0.5. Finally, 100% of patients fully recovered in the treatment group vs 98.8% in the placebo group. No severe adverse events were reported throughout the trial. Conclusions: Our results showed that daily doses of Melatonin, zinc and vitamins did significantly reduce the duration of symptoms accelerating its disappearance among patients consulting with COVID-19 or COVID-19 like illness.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 50 条
  • [1] COVID-19 prophylaxis with doxycycline and zinc in health care workers: a prospective, randomized, double-blind clinical trial
    Stambouli, Nejla
    Driss, Adel
    Gargouri, Faten
    Bahrini, Khadija
    Arfaoui, Bilel
    Abid, Rim
    Taamallah, Karima
    Hannachi, Souha
    Boughariou, Sana
    Rebai, Aicha
    Naas, Imen
    Ghanem, Mohamed
    Ammar, Hassib
    Aichaouia, Chiraz
    Harrathi, Asma
    Yousfi, Mohamed Ali
    Battikh, Riadh
    Ben Moussa, Mohamed
    Razgallah, Rabie
    Ferjani, Mustapha
    Gharsallah, Hedi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 553 - 558
  • [2] Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
    Jain, Mamta K.
    De Lemos, James A.
    McGuire, Darren K.
    Ayers, Colby.
    Eitson, Jennifer L.
    Sanchez, Claudia L.
    Kamel, Dena
    Meisner, Jessica A.
    Thomas, Emilia V.
    Hegde, Anita A.
    Mocherla, Satish
    Strebe, Joslyn K.
    Li, Xilong
    Williams, Noelle S.
    Xing, Chao
    Ahmed, Mahmoud S.
    Wang, Ping
    Sadek, Hesham A.
    Schoggins, John W.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Bosentan and Pulmonary Hypertension Caused by COVID-19: A Pilot Randomized Double-blind Clinical Study
    Shokrollahi, Fahime
    Pazoki, Ali
    Allami, Abbas
    Aliakbari, Shahin
    Ardali, Kimia Rahimi
    CURRENT VASCULAR PHARMACOLOGY, 2024, 22 (06) : 437 - 446
  • [4] Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial
    Shahbaznejad, Leila
    Davoudi, Alireza
    Eslami, Gohar
    Markowitz, John S.
    Navaeifar, Mohammad Reza
    Hosseinzadeh, Fatemeh
    Movahedi, Faeze Sadat
    Rezai, Mohammad Sadegh
    CLINICAL THERAPEUTICS, 2021, 43 (06) : 1007 - 1019
  • [5] Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial
    Farnoosh, Gholamreza
    Akbariqomi, Mostafa
    Badri, Taleb
    Bagheri, Mahdi
    Izadi, Morteza
    Saeedi-Boroujeni, Ali
    Rezaie, Ehsan
    Ghaleh, Hadi Esmaeili Gouvarchin
    Aghamollaei, Hossein
    Fasihi-Ramandi, Mahdi
    Hassanpour, Kazem
    Alishiri, GholamHossein
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (01) : 79 - 85
  • [6] Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients
    Ulrich, Robert J.
    Troxel, Andrea B.
    Carmody, Ellie
    Eapen, Jaishvi
    Backer, Martin
    DeHovitz, Jack A.
    Prasad, Prithiv J.
    Li, Yi
    Delgado, Camila
    Jrada, Morris
    Robbins, Gabriel A.
    Henderson, Brooklyn
    Hrycko, Alexander
    Delpachitra, Dinuli
    Raabe, Vanessa
    Austrian, Jonathan S.
    Dubrovskaya, Yanina
    Mulligan, Mark J.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (10):
  • [7] Trace Minerals, Vitamins and Nutraceuticals in Prevention and Treatment of COVID-19
    Srivastava, Ajay
    Gupta, Ramesh C.
    Doss, Robin B.
    Lall, Rajiv
    JOURNAL OF DIETARY SUPPLEMENTS, 2022, 19 (03) : 395 - 429
  • [8] Hydrogen peroxide as an auxiliary treatment for COVID-19 in Brazil: a randomized double-blind clinical trial
    Di Domenico, Marielle Bazzo
    Collares, Kaue
    Dos Santos, Renan Brandenburg
    Lenz, Ulysses
    Antunes, Vinicius Picoli
    Godinho, Vinicius Webber
    Cesca, Henrique
    Jincziwski Ponciano, Thales Henrique
    Corazza, Pedro Henrique
    EPIDEMIOLOGY AND HEALTH, 2021, 43
  • [9] Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19
    Sabitov, Alebai U.
    Lioznov, Dmitry A.
    Zhdanov, Konstantin V.
    Tihonova, Elena P.
    Esaulenko, Elena V.
    Sorokin, Pavel V.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (03) : 280 - 285
  • [10] Efficacy and safety of short-wave diathermy treatment for moderate COVID-19 patients: a prospective, double-blind, randomized controlled clinical study
    Tian, Fei
    Wang, Jin
    Xi, Xiao
    Sun, Xiaolong
    He, Miao
    Zhao, Chenguang
    Feng, Feng
    Wang, Hongbin
    Sun, Wei
    Mao, Li
    Hu, Xu
    Yuan, Hua
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2022, 58 (01) : 137 - 143